Select Committee on Science and Technology Minutes of Evidence


Examination of Witnesses (Questions 57-59)

MR PATRICK MCDONALD, MR STEVE COLDRICK, MR CHRIS WELLS, DR PETER WRIGHT AND MS ANNE KIRKHAM

22 NOVEMBER 2006

  Q57Chairman: Can I welcome you here to our first day of taking oral evidence for our Committee inquiry. I would like just to remind you that this session is being broadcast and also that the individual Committee members have completed a declaration of interests which is available to the public, so we will not be formally declaring our interests to you as we ask you questions. We will ask you questions and if there are supplementary issues that you wish to submit later to this evidence session then we will be very happy to receive them. I wonder if you might start by each introducing yourself.

  Mr McDonald: I am Patrick McDonald, the Chief Scientist at the Health and Safety Executive, and with me this morning is Steve Coldrick, who is looking after our Disease Reduction Programme.

  Mr Coldrick: I am Steve Coldrick, Head of the Health and Safety Executive's Disease Reduction Programme.

  Mr Wells: I am Chris Wells and I am the Head of Special Educational Needs and Disability at the Department for Education and Skills.

  Ms Kirkham: I am Anne Kirkham and I am Deputy Director in DCLG responsible for Decent Homes Finance and Mixed Communities.

  Dr Wright: I am Peter Wright, the Principal Scientific Adviser at the Department for Work and Pensions.

  Q58  Chairman: I would like to start the questions, if I may, and it is specifically really for the Health and Safety Executive and the Department for Work and Pensions. In the evidence submitted to us you say that it is difficult to estimate the proportion of workers who have lung and skin problems that are actually allergic related—asthma and allergic contact dermatitis. I wonder what plans there are to try to record accurately the number of workers who are suffering from these allergic conditions.

  Mr McDonald: If I may start with a description of where we get our data from. The lead data source for occupational illness is a population-based survey on self-reported work-related illness, and from that we derive population estimates. Despite using what is the biggest survey system available to government statisticians, this picks up fairly few cases of occupational illness, and the bulk of those are musculoskeletal problems and mental health problems. There are just too few cases of occupational lung and skin disease in the survey on which to base any reliable estimates of particular types of skin and lung disease, so we rely quite heavily on the voluntary reporting scheme which is run for us by Manchester University, and it relies on GPs and other consultant specialists. The scheme is called The Occupational Health Reporting Scheme, and we also take into account other administrative data sources such as the Industrial Injuries Scheme, and it is on these figures that our assessment of trends are based. That is broadly adequate for monitoring whether or not we hit the Health and Safety Executive's targets but it is not adequate for targeting our interventions very closely, so we have just commissioned an addition to the THOR reporting scheme which is based on GPs who have had occupational health training[1], and we are rather hopeful that that will improve the accuracy with which we can report on occupational asthma and contact dermatitis. There is also a broader engagement by the Health and Safety Executive in trying to measure the awareness and attitudes to specific health and safety issues within firms and monitoring consequent improvements in health and safety outcomes. I hope with time we will be able to draw more firm conclusions on self-reported occupational asthma and contact dermatitis.

  Q59Chairman: Are these going to be GP indexed practices that you are going to be using to collect the data?

  Mr Coldrick: I cannot say for certain whether it is that, but what I do know is that we have to make sure that GPs are fully aware of recognising particular conditions, and that is why there has been this training. It has been an issue of concern for some time so I expect the training to be for GPs at the indexed practices rather than for all GPs.


1   The THOR network of reporting GPs was added more recently to the overall THOR scheme to capture a wider spectrum of disease severity. Back


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2007